by Lee Ji-yoon
Published : Nov. 6, 2026 - 15:36:18
Cell Biotech disclosed Friday that its third-quarter consolidated operating profit fell 9.4 percent on-year to 2.007 billion won ($1.5 million).
Revenue for the same period came in at 14.848 billion won, down 3.3 percent, according to preliminary figures.
The company swung to a net loss of 4.268 billion won in the quarter.
This content was produced with the assistance of AI translation services.
Celltrion's quadruple-action obesity drug outperforms triple agonist in animal tests
Nov. 4, 2026
SK Bioscience joins $99M US-backed project to develop Bundibugyo Ebola vaccine
Oct. 29, 2026
Broadcaster Kim Dong-hyun's Apgujeong apartment drops W1.2b within a month of purchase
Nov. 4, 2026
Viral post claiming Musk proposed app for billionaires to pay strangers' bills is false
Nov. 4, 2026
Hanwha closes in on Austal USA acquisition, eyes second US shipyard
Nov. 4, 2026
